Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: Two cases

General Hospital Psychiatry

Volumn 33, Issue 6, 2011, Pages 640.e5-640.e6

  Antonowicz, Joseph L ^a   Metzger, Amy K ^a   Ramanujam, Sai L ^a  

^a Altoona Regional Health System   (United States)

Author keywords

Blizzard; Methylenedioxypyrovalerone; Paranoid psychosis

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; METHYLENEDIOXYPYROVALERONE; PYROVALERONE; RISPERIDONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; DELUSION; DRUG DETOXIFICATION; FEMALE; HALLUCINATION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MALE; MEMORY DISORDER; OPIATE ADDICTION; PARANOID PSYCHOSIS; PATIENT TRANSPORT; THOUGHT DISORDER; TOXICITY TESTING;

EID: 81955166874     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2011.04.010     Document Type: Article

References (5)

1. Nichols D. Legal highs: the dark side of medicinal chemistry. Nature 2011, 469(7328):7.
2. Meltzer P.C., Butler D., Deschamps J.R., Madras B.K. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem 2006, 49(4):1420-1432.
3. Pennsylvania Dept. of Health, 2/2011, http://www.portal.state.pa.us/portal/server.pt/Bath%20Salts%20Fact%20Sheet%202%5b1%5d.211.pdf.
4. McCandless D., 16FEB2004, http://www.guardian.co.uk/society/2004/feb/16/drugsandalcohol.drugs/print.
5. Brandt S.D., Freeman S., Sumnall H.R., Measham F., Cole J. Analyses of "legal highs" in the UK: initial findings. Drug Test Anal 2010, 2(8):377-382.